Julie Bataille

  • Citations Per Year
Learn More
Off-label or unlicensed medicine use is very common in paediatric practice, ranging from 11 to 80 %, and is one of the predisposing factors for adverse events (23–60 %). Medicine indications are the third leading reason for doctors to perform off-label prescriptions. The aim of our study was to determine the prevalence and nature of off-label and unlicensed(More)
PURPOSE The lack of drugs specifically assessed for paediatric use results in a widespread off-label drug use. The aim of this work is to identify experiences and attitudes towards paediatrics off-label prescribing in a university teaching paediatric hospital. METHODS A questionnaire of 24 items was sent by email to 409 paediatricians in February 2013. (More)
RATIONALE, AIMS AND OBJECTIVES High-alert medications (HAMs) are medications that are associated with a high risk of serious harm if used improperly. The objective of this study was to identify paediatric HAM used in our institution and to identify safety measures for their use. METHODS The list of HAM and the list of safety measures that were introduced(More)
As drug delivery activity to outpatients in precarious situation is rising continuously, the goal of this work was to perform an assessment of the professional practices of the care pathway of these patients, called PASS in France (permanence d'accès aux soins de santé). At first, two pharmacists did an audit of this care pathway. Then, options for(More)
INTRODUCTION The European Society for Clinical Nutrition has published recommendations on the 'definition and classification of intestinal failure (IF)'. Two criteria must be present: a 'decreased absorption of macronutrients and/or water and electrolytes due to a loss of gut function' and the 'need for parenteral support'. Home parenteral support (HPS) is(More)
Figure 1 Tuméfaction du pied droit (cas n 1) La tuberculose (TB) est une maladie à déclaration obligatoire. En 2012, on estimait le nombre de nouveaux cas à 8,6 millions dans le monde, diminuant de 2 % chaque année [1]. La vaccination par le BCG (Mycobacterium bovis souche atténuée) a une efficacité de 75 % et 85 % pour les formes graves de TB (méningite et(More)